文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

糖尿病病程与急性心肌梗死后住院患者的死亡率。

Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction.

机构信息

Lab of Cardiovascular Prevention Dipt of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.

Centro Cardiologico Monzino IRCCS, Milan, Italy.

出版信息

Cardiovasc Diabetol. 2022 Oct 29;21(1):223. doi: 10.1186/s12933-022-01655-w.


DOI:10.1186/s12933-022-01655-w
PMID:36309742
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9618227/
Abstract

BACKGROUND: Diabetes mellitus (DM) is associated with an increased mortality risk in patients hospitalized with acute myocardial infarction (AMI); however, no studies have investigated the impact of the duration of DM on in-hospital mortality. In this study, we evaluated in-hospital mortality in AMI patients according to DM status and its duration. METHODS: Using health administrative databases of Lombardy, DM patients≥50 years hospitalized with AMI from 2010 to 2019 were included in the analysis and were stratified according to the duration of DM: <5, 5-10, and > 10 years. The primary endpoint was mortality during AMI hospitalization and the secondary endpoint was 1-year mortality in comparison with No-DM patients. Logistic and Cox regressions analyses were used to estimate odds ratios (ORs, CI 95%) and hazard ratios (HRs, CI 95%) for the outcomes, according to DM status and duration and AMI type (STEMI and NSTEMI). RESULTS: Our study cohort comprised 29,566 and 109,247 DM and No-DM patients, respectively. Adjusted ORs and HRs showed a significantly higher risk of in-hospital mortality (OR 1.50, 95% CI 1.43-1.58) and 1-year mortality (HR 1.51, 95% CI 1.46-1.55) in DM patients in comparison with those without. These risks increased progressively with the duration of DM, with the highest risk observed in patients with DM duration ≥ 10 years (OR 1.59, 95% CI 1.50-1.69 for in-hospital mortality and HR 1.59, 95% CI 1.53-1.64 for 1-year mortality). These findings were similar in STEMI and in NSTEMI patients. CONCLUSIONS: Our study demonstrates that the duration of DM parallels mortality risk in patients hospitalized with AMI, highlighting that DM duration should be considered as an important early prognostic risk factor in patients with AMI.

摘要

背景:糖尿病(DM)与急性心肌梗死(AMI)住院患者的死亡率增加相关;然而,尚无研究调查 DM 持续时间对住院死亡率的影响。本研究评估了根据 DM 状态及其持续时间,AMI 患者的住院死亡率。

方法:使用伦巴第大区的健康管理数据库,纳入了 2010 年至 2019 年期间年龄≥50 岁因 AMI 住院的 DM 患者,并根据 DM 的持续时间进行分层:<5 年、5-10 年和>10 年。主要终点是 AMI 住院期间的死亡率,次要终点是与无 DM 患者相比的 1 年死亡率。根据 DM 状态和持续时间以及 AMI 类型(STEMI 和 NSTEMI),使用逻辑和 Cox 回归分析估计结局的比值比(OR,95%置信区间)和风险比(HR,95%置信区间)。

结果:本研究队列包括 29566 例 DM 患者和 109247 例无 DM 患者。调整后的 OR 和 HR 显示,DM 患者的住院死亡率(OR 1.50,95%CI 1.43-1.58)和 1 年死亡率(HR 1.51,95%CI 1.46-1.55)显著更高。这些风险随着 DM 的持续时间而逐渐增加,DM 持续时间≥10 年的患者风险最高(住院死亡率的 OR 1.59,95%CI 1.50-1.69;1 年死亡率的 HR 1.59,95%CI 1.53-1.64)。这些发现在 STEMI 和 NSTEMI 患者中相似。

结论:本研究表明,DM 的持续时间与 AMI 住院患者的死亡率风险相关,突出表明 DM 持续时间应被视为 AMI 患者的一个重要早期预后危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e91/9618227/530922810e54/12933_2022_1655_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e91/9618227/819b98ab53b5/12933_2022_1655_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e91/9618227/0c728ae3d88c/12933_2022_1655_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e91/9618227/45d1484247ad/12933_2022_1655_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e91/9618227/530922810e54/12933_2022_1655_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e91/9618227/819b98ab53b5/12933_2022_1655_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e91/9618227/0c728ae3d88c/12933_2022_1655_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e91/9618227/45d1484247ad/12933_2022_1655_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e91/9618227/530922810e54/12933_2022_1655_Fig4_HTML.jpg

相似文献

[1]
Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction.

Cardiovasc Diabetol. 2022-10-29

[2]
In-hospital outcomes and 5-year mortality following an acute myocardial infarction in patients with a history of cancer: Results from the French registry on Acute ST-elevation or non-ST-elevation myocardial infarction (FAST-MI) 2005 cohort.

Arch Cardiovasc Dis. 2019-11-21

[3]
Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus.

Cardiovasc Diabetol. 2020-10-20

[4]
Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.

Cardiovasc Diabetol. 2021-10-19

[5]
Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute Myocardial Infarction: The SILVER-AMI Study.

Circ Cardiovasc Qual Outcomes. 2019-10

[6]
Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR).

Am J Cardiol. 2014-10-15

[7]
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registry.

Clin Res Cardiol. 2024-4

[8]
Are there sex differences in the effect of type 2 diabetes in the incidence and outcomes of myocardial infarction? A matched-pair analysis using hospital discharge data.

Cardiovasc Diabetol. 2021-4-22

[9]
Diabetes and Mortality in Acute Coronary Syndrome: Findings from the Gulf COAST Registry.

Curr Vasc Pharmacol. 2020

[10]
Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.

Heart Vessels. 2016-11

引用本文的文献

[1]
β-blocker and clinical outcomes in patients after myocardial infarction: a systematic review and meta-analysis.

Eur J Clin Pharmacol. 2025-9-9

[2]
Inflammatory markers guide early risk stratification and prognosis in elderly patients with acute myocardial infarction.

Sci Rep. 2025-8-19

[3]
Glycemic Comparison Index (GCI): a retrospective analysis of its prognostic value in ICU patients with AMI and diabetes.

BMC Endocr Disord. 2025-3-26

[4]
Independent influence of type 2 diabetes on reduced cardiopulmonary fitness in patients after percutaneous coronary intervention: a cross-sectional study.

Sci Rep. 2025-2-19

[5]
Machine learning approaches for risk prediction after percutaneous coronary intervention: a systematic review and meta-analysis.

Eur Heart J Digit Health. 2024-10-14

[6]
Plasma tissue plasminogen activator-inhibitor complex levels in acute myocardial infarction patients: an observational study.

BMC Cardiovasc Disord. 2024-12-20

[7]
Short- and long-term mortality in patients with type 2 diabetes after myocardial infarction- a nationwide registry study.

Cardiovasc Diabetol. 2024-10-30

[8]
In-Hospital Mortality in Patients With Acute Myocardial Infarction: A Literature Overview.

Cureus. 2024-8-12

[9]
Association of Iron Therapy with Mortality in Patients with Acute Myocardial Infarction and Iron Deficiency.

Cardiovasc Toxicol. 2024-10

[10]
Prognostic Impact of Percutaneous Coronary Intervention in Chronic Dialysis Patients with Acute Myocardial Infarction: .

Rev Cardiovasc Med. 2023-4-28

本文引用的文献

[1]
Three-year mortality after acute myocardial infarction in patients with different diabetic status.

Pol Arch Intern Med. 2021-11-30

[2]
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets.

Lancet. 2021-1-16

[3]
Comparison of Short- and Long-Term Prognosis between ST-Elevation and Non-ST-Elevation Myocardial Infarction.

J Clin Med. 2021-1-7

[4]
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Eur Heart J. 2021-4-7

[5]
Diabetes Mellitus and Acute Myocardial Infarction: Impact on Short and Long-Term Mortality.

Adv Exp Med Biol. 2021

[6]
Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.

BMC Cardiovasc Disord. 2020-1-30

[7]
Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study.

Cardiovasc Diabetol. 2019-11-16

[8]
Relationships of coronary culprit-plaque characteristics with duration of diabetes mellitus in acute myocardial infarction: an intravascular optical coherence tomography study.

Cardiovasc Diabetol. 2019-10-19

[9]
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Eur Heart J. 2020-1-7

[10]
Reduced Cardio-Renal Function Accounts for Most of the In-Hospital Morbidity and Mortality Risk Among Patients With Type 2 Diabetes Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.

Diabetes Care. 2019-5-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索